A multicenter survey study of antifibrotic use for symptomatic patients with post-COVID-19 interstitial lung abnormalities.

Sahajal Dhooria,Venkata Nagarjuna Maturu,Deepak Talwar,Sachin Kumar,Ajay Handa, Priya Nath Agrawal,Aditya Jindal, P S Tampi,Abhishek Goyal,Dipesh Maskey,Ashutosh Nath Aggarwal,Digambar Behera,Surinder Kumar Jindal

Lung India : official organ of Indian Chest Society（2022）

引用 1|浏览7

暂无评分

摘要

Antifibrotic agents were administered to a minority of patients discharged after recovery from acute COVID-19 pneumonia. Larger, randomized studies on the efficacy and safety of these agents are required.

查看译文

关键词

Coronavirus disease 2019,diffuse lung disease,interstitial lung disease,lung fibrosis,nintedanib,pirfenidone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要